Research Projects

Proposal Date

Project Title

Principal Investigator(s)

Status

09/01/2011

Risk factors by aggressiveness

Fortner

Published

09/01/2011

Risk factors by histologic subtype

Wentzensen

Published

09/01/2011

Risk factors by tumor dominance

Tworoger, Arslan, Visvanathan, Patel, Wentzensen

Published

09/01/2011

Risk prediction modeling accounting for tumor subtype

Tworoger, Arslan, Visvanathan, Patel, Wentzensen

Ongoing

02/08/2012

Aspirin, non-aspirin NSAID, acetaminophen use and ovarian cancer risk

Trabert

Published

02/08/2012

Endometriosis and histologic subtypes of ovarian cancer

Trabert

Published

09/01/2012

Base risk prediction model in US Caucasian women (with OCAC)

Tworoger, Schildkraut, Iversen

Ongoing

10/01/2012

Androgens and ovarian cancer risk

Kaaks

Published

10/01/2012

IGF-I and risk of ovarian cancer risk

Kaaks

Published

11/05/2012

Inflammation-related exposures and risk of ovarian cancer, CRP

Poole

Published

06/01/2013

OncoArray (GWAS)

Wentzensen, Tworoger

Ongoing

11/03/2014

Risk factors by primary site

Rice, Schouten, Fortner

Published

05/14/2015

Hypertension, antihypertensive medications, and ovarian cancer: OC3

Tworoger

Ongoing

07/26/2015

Correlates of long-term survival in serous ovarian cancer: OC3

Tworoger

Ongoing

08/03/2015

Exposure-wide association study of high-grade serous ovarian cancer: OC3

Trabert, Tworoger

Ongoing

09/22/2015

Lifetime ovulatory cycles and ovarian cancer risk in OC3

Trabert

Published

09/07/2016

Identification of immune-proteomic markers for ovarian cancer detection

Kaaks

Ongoing

09/14/2016

Coffee, tea, and caffeine consumption and ovarian cancer risk

Harris

Ongoing

10/20/2016

Epigenetic risk marker for ovarian cancer

Flanagan

Ongoing

12/16/2016

Diabetes and ovarian cancer risk

Harris

Ongoing

06/16/2017

Genetic predictors of CA125

Terry

Ongoing

11/01/2017

Understanding racial and ethnic differences in epithelial ovarian cancer risk and survival

Merritt

Ongoing

01/16/2018

Talc and gynecologic cancer risk (An OC3 analysis)

O'Brien, Wentzensen, Sandler

Published

05/14/2018

Pre- and post-diagnosis analgesic use and ovarian cancer survival

Merritt

Ongoing

09/19/2018

Making the CASE: Chemopreventive Use of Aspirin for Ovarian Cancer - Integrating Epidemiological Data to Evaluate Population Subgroups and Tumor Expression

Trabert

Ongoing

01/14/2019

Risk factors among women with endometriosis

Harris

Ongoing

04/11/2019

IUD use and ovarian cancer risk

Terry

Ongoing

07/09/2019

Breastfeeding and ovarian cancer risk and survival

Sasamoto, Terry

Ongoing

02/11/2020

Hormone therapy and risk

O'Brien, Harris, Sandler, Tworoger

Ongoing

05/10/2021

Statins and ovarian cancer risk

Zeleznik

Ongoing

08/10/2021

Hormone therapy and survival

Sasamoto

Ongoing

08/19/2021

Antibodies against chlamydia trachomatis and other infections and ovarian cancer histotypes

Trabert, Fortner

Ongoing


Publications

10. Fortner, R. T., Rice, M. S., Knutsen, S. F., Orlich, M. J., Visvanathan, K., Patel, A. V., . . . Schouten, L. J. (2020). Ovarian cancer risk factor associations by primary anatomic site: The Ovarian Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. doi:10.1158/1055-9965.EPI-20-0354 

 

9.  Trabert, B., Tworoger, S. S., O'Brien, K. M., Townsend, M. K., Fortner, R. T., Iversen, E. S., . . . Wentzensen, N. (2020). The risk of ovarian cancer increases with an increase in the lifetime number of ovulatory cycles: an analysis from the Ovarian Cancer Cohort Consortium (OC3). Cancer Res. doi:10.1158/0008-5472.CAN-19-2850 

 

8.  O'Brien, K. M., Tworoger, S. S., Harris, H. R., Anderson, G. L., Weinberg, C. R., Trabert, B., . . . Wentzensen, N. (2020). Association of Powder Use in the Genital Area With Risk of Ovarian Cancer. JAMA, 323(1), 49-59. doi:10.1001/jama.2019.20079

 

7.  Huang, T., Townsend, M. K., Wentzensen, N., Trabert, B., White, E., Arslan, A. A., . . . Tworoger, S. S. (2019). Reproductive and Hormonal Factors and Risk of Ovarian Cancer by Tumor Dominance: Results from the Ovarian Cancer Cohort Consortium (OC3). Cancer Epidemiol Biomarkers Prev. doi:10.1158/1055-9965.EPI-19-0734

 

6.  Peres, L. C., Mallen, A. R., Townsend, M. K., Poole, E. M., Trabert, B., Allen, N. E., . . . Tworoger, S. S. (2019). High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium. Cancer Res, 79(20), 5442-5451. doi:10.1158/0008-5472.CAN-19-1554

 

5.  Trabert, B., Poole, E. M., White, E., Visvanathan, K., Adami, H. O., Anderson, G. L., . . . Ovarian Cancer Cohort, C. (2019). Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium. J Natl Cancer Inst, 111(2), 137-145. doi:10.1093/jnci/djy100

 

4.  Fortner, R. T., Poole, E. M., Wentzensen, N. A., Trabert, B., White, E., Arslan, A. A., . . . Tworoger, S. S. (2018). Ovarian cancer risk factors by tumor aggressiveness: an analysis from the Ovarian Cancer Cohort Consortium. Int J Cancer. doi:10.1002/ijc.32075 

 

3.  Ose, J., Poole, E. M., Schock, H., Lehtinen, M., Arslan, A. A., Zeleniuch-Jacquotte, A., . . . Fortner, R. T. (2017). Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort Consortium. Cancer Res, 77(14), 3951-3960. doi:10.1158/0008-5472.CAN-16-3322

 

2.  Ose, J., Schock, H., Poole, E. M., Lehtinen, M., Visvanathan, K., Helzlsouer, K., . . . Fortner, R. T. (2017). Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium. Cancer Causes Control, 28(5), 429-435. doi:10.1007/s10552-017-0852-8

 

1.  Wentzensen, N., Poole, E. M., Trabert, B., White, E., Arslan, A. A., Patel, A. V., . . . Tworoger, S. S. (2016). Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. J Clin Oncol, 34(24), 2888-2898. doi:10.1200/JCO.2016.66.8178